Milestone Pharmaceuticals Inc. (MIST)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $82k
- Apr 16 · Routine
- Form 4 sales
- 10
- On record
- Form 144 notices
- 3
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Apr 16, 2026Routine
Oliveto Joseph, President and CEO, sold 7.6% of their holdings
$82k36,500 shares at $2.26
- Apr 16, 2026Notice
Oliveto Joseph, President and CEO, filed a notice to sell 36,500 shares
$80k36,500 shares
- Jan 26, 2026Unusual
Nelson Jeffrey Edward, Chief Operating Officer, sold 58.5% of their holdings
$158k70,252 shares at $2.25
- Jan 26, 2026Unusual
Bharucha David, Chief Medical Officer, sold 38.3% of their holdings
$158k70,252 shares at $2.25
- Jan 26, 2026Unusual
Hasija Amit, CFO & EVP of Corp. Development, sold 41.3% of their holdings
$158k70,252 shares at $2.25
- Jan 26, 2026No plan
Muller Lorenz, Chief Commercial Officer, sold 24% of their holdings
$146k64,746 shares at $2.25
- Jan 26, 2026Unusual
Oliveto Joseph, President and CEO, sold 25.8% of their holdings
$375k167,577 shares at $2.24
- Jan 8, 2026Routine
Oliveto Joseph, President and CEO, sold 12.5% of their holdings
$98k43,500 shares at $2.25
- Jan 8, 2026Notice
Oliveto Joseph, President and CEO, filed a notice to sell 79,500 shares
$171k79,500 shares
- Jan 7, 2026Notice
Oliveto Joseph, President and CEO, filed a notice to sell 500 shares
$1k500 shares
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 12, 2026 | MIST | Duty Stuart | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Wills Robert James | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Saik Andrew | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Fischer Seth H. Z. | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Tomsicek Michael John | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Giles Lisa M. | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Papa Joseph C | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Apr 16, 2026 | Apr 20, 2026 | MIST | Oliveto Joseph | President and CEO | Sold | 36,500 | $2.26 | $82k | 446,244 | SEC |
| Feb 2, 2026 | Feb 4, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | AwardedEmployee Stock Option (right to buy) | 340,000 | 136,000 | SEC | ||
| Feb 2, 2026 | Feb 4, 2026 | MIST | Bharucha David | Chief Medical Officer | AwardedEmployee Stock Option (right to buy) | 340,000 | 136,000 | SEC | ||
| Feb 2, 2026 | Feb 4, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | AwardedEmployee Stock Option (right to buy) | 340,000 | 136,000 | SEC | ||
| Feb 2, 2026 | Feb 4, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | AwardedEmployee Stock Option (right to buy) | 340,000 | 136,000 | SEC | ||
| Feb 2, 2026 | Feb 4, 2026 | MIST | Oliveto Joseph | President and CEO | AwardedEmployee Stock Option (right to buy) | 1.1M | 453,000 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | Sold | 70,252 | $2.25 | $158k | 49,848 | SEC |
| Jan 26, 2026 | Jan 28, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | Exercised or settledRestricted Stock Units | 20,100 | 60,300 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | Exercised options | 20,100 | 62,093 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Bharucha David | Chief Medical Officer | Sold | 70,252 | $2.25 | $158k | 113,181 | SEC |
| Jan 26, 2026 | Jan 28, 2026 | MIST | Bharucha David | Chief Medical Officer | Exercised or settledRestricted Stock Units | 20,100 | 60,300 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Bharucha David | Chief Medical Officer | Exercised options | 20,100 | 125,426 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | Sold | 70,252 | $2.25 | $158k | 99,848 | SEC |
| Jan 26, 2026 | Jan 28, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | Exercised or settledRestricted Stock Units | 20,100 | 60,300 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | Exercised options | 20,100 | 112,093 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | Sold | 64,746 | $2.25 | $146k | 205,406 | SEC |
| Jan 26, 2026 | Jan 28, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | Exercised or settledRestricted Stock Units | 20,100 | 60,300 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | Exercised options | 20,100 | 216,586 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Oliveto Joseph | President and CEO | Sold | 167,577 | $2.24 | $375k | 482,744 | SEC |
| Jan 26, 2026 | Jan 28, 2026 | MIST | Oliveto Joseph | President and CEO | Exercised or settledRestricted Stock Units | 66,600 | 199,800 | SEC | ||
| Jan 26, 2026 | Jan 28, 2026 | MIST | Oliveto Joseph | President and CEO | Exercised options | 66,600 | 517,267 | SEC | ||
| Jan 8, 2026 | Jan 9, 2026 | MIST | Oliveto Joseph | President and CEO | Sold | 43,500 | $2.25 | $98k | 303,721 | SEC |
| Dec 12, 2025 | Jan 28, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | AwardedEmployee Stock Option (right to buy) | 100,000 | 100,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Nelson Jeffrey Edward | Chief Operating Officer | Awarded | 100,000 | 100,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Bharucha David | Chief Medical Officer | AwardedEmployee Stock Option (right to buy) | 100,000 | 100,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Bharucha David | Chief Medical Officer | Awarded | 100,000 | 163,333 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | AwardedEmployee Stock Option (right to buy) | 100,000 | 100,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Hasija Amit | CFO & EVP of Corp. Development | Awarded | 100,000 | 150,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | AwardedEmployee Stock Option (right to buy) | 100,000 | 100,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Muller Lorenz | Chief Commercial Officer | Awarded | 100,000 | 250,052 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Oliveto Joseph | President and CEO | AwardedEmployee Stock Option (right to buy) | 280,000 | 280,000 | SEC | ||
| Dec 12, 2025 | Jan 28, 2026 | MIST | Oliveto Joseph | President and CEO | Awarded | 280,000 | 583,721 | SEC | ||
| Dec 9, 2025 | Dec 11, 2025 | MIST | Muller Lorenz | Chief Commercial Officer | Gift | 25,000 | 150,052 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Liebert Debra K. | Director | AwardedSeries A Common Warrants (right to buy) | 33,586 | 16,793 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Liebert Debra K. | Director | Awarded | 16,666 | 16,793 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Hasija Amit | CFO & EVP of Corp. Development | AwardedSeries A Common Warrants (right to buy) | 100,000 | 50,000 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Hasija Amit | CFO & EVP of Corp. Development | Awarded | 50,000 | 50,000 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Wills Robert James | Director | AwardedSeries A Common Warrants (right to buy) | 100,000 | 50,000 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Wills Robert James | Director | Awarded | 50,000 | 65,000 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Bharucha David | Chief Medical Officer | AwardedSeries A Common Warrants (right to buy) | 106,666 | 53,333 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Bharucha David | Chief Medical Officer | Awarded | 53,333 | 63,333 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Oliveto Joseph | President and CEO | AwardedSeries A Common Warrants (right to buy) | 133,332 | 66,666 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Oliveto Joseph | President and CEO | Awarded | 66,666 | 347,221 | SEC |
Sales, notices and lockups (13)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 20, 2026 | Oliveto Joseph | MIST | President and CEO | Form 4 sale | 36,500 | $82k | 7.6% | Routine | SEC |
| Apr 16, 2026 | Apr 16, 2026 | Oliveto Joseph | MIST | President and CEO | Form 144 notice | 36,500 | $80k | Notice | SEC | |
| Jan 26, 2026 | Jan 28, 2026 | Nelson Jeffrey Edward | MIST | Chief Operating Officer | Form 4 sale | 70,252 | $158k | 58.5% | Unusual | SEC |
| Jan 26, 2026 | Jan 28, 2026 | Bharucha David | MIST | Chief Medical Officer | Form 4 sale | 70,252 | $158k | 38.3% | Unusual | SEC |
| Jan 26, 2026 | Jan 28, 2026 | Hasija Amit | MIST | CFO & EVP of Corp. Development | Form 4 sale | 70,252 | $158k | 41.3% | Unusual | SEC |
| Jan 26, 2026 | Jan 28, 2026 | Muller Lorenz | MIST | Chief Commercial Officer | Form 4 sale | 64,746 | $146k | 24.0% | No plan | SEC |
| Jan 26, 2026 | Jan 28, 2026 | Oliveto Joseph | MIST | President and CEO | Form 4 sale | 167,577 | $375k | 25.8% | Unusual | SEC |
| Jan 8, 2026 | Jan 9, 2026 | Oliveto Joseph | MIST | President and CEO | Form 4 sale | 43,500 | $98k | 12.5% | Routine | SEC |
| Jan 8, 2026 | Jan 8, 2026 | Oliveto Joseph | MIST | President and CEO | Form 144 notice | 79,500 | $171k | Notice | SEC | |
| Jan 7, 2026 | Jan 7, 2026 | Oliveto Joseph | MIST | President and CEO | Form 144 notice | 500 | $1k | Notice | SEC | |
| Sep 7, 2022 | Sep 9, 2022 | Rtw Investments, LP | MIST | 10% owner | Form 4 sale | 1.6M | $13.6M | 26.5% | Unusual | SEC |
| Jul 29, 2020 | Jul 30, 2020 | Fonds De Solidarite Des Travailleurs Du Quebec | MIST | 10% owner | Form 4 sale | 519,863 | $4.3M | 18.7% | Plan not stated | SEC |
| Nov 25, 2019 | Nov 27, 2019 | Novo Holdings A/S | MIST | 10% owner | Form 4 sale | 240,000 | $3.8M | 9.0% | Plan not stated | SEC |